US Urinalysis Test Market Size Study, by Product (Instruments, Consumables), by Application (Disease screening, Pregnancy and fertility), by End User (Hospitals and clinics, Diagnostic laboratories, Home care) Forecasts 2022-2032
US Urinalysis Test Market is valued at approximately USD 810.15 million in 2023 and is anticipated to grow with a healthy growth rate of more than 1.18% over the forecast period 2024-2032. Urinalysis is a vital diagnostic test that provides insights into the urinary system's health by analyzing urine's physical, chemical, and microscopic properties. Urine colour and transparency indicate hydration and potential substances such as proteins or bacteria. Specific gravity measures urine concentration, reflecting hydration levels, while pH levels show how diet and health conditions affect urine acidity. Proteinuria signals kidney issues, glucose suggests diabetes, and ketones indicate fat use for energy. Microscopic analysis aids in diagnosing kidney disease by detecting cells, bacteria, and crystals. Early identification of medical issues through urinalysis enables prompt treatment. The US Urinalysis Test market is growing due to the rising prevalence of chronic diseases such as diabetes and kidney disorders, increasing the demand for early detection and monitoring. The adoption of point-of-care testing for quick diagnostics, technological advancements in automated systems, and the COVID-19 pandemic's emphasis on regular health monitoring further propel market growth, making it a key focus for healthcare providers and manufacturers.
The US Urinalysis Test Market is being driven by the increasing prevalence of chronic diseases, such as diabetes and kidney disorders, which necessitate regular urinalysis testing for early detection and management. This trend is particularly important as early intervention significantly improves patient outcomes and reduces healthcare costs. Additionally, the market is benefiting from the growing adoption of Point-Of-Care Testing (POCT), which offers rapid and convenient diagnostics, especially in remote or resource-limited settings However, there are also restraints impacting the market such as high costs of advanced equipment, economic disparities that restrict investment in new technologies, stringent regulatory requirements causing delays in product introduction, disparities in healthcare access impacting testing availability, limited awareness about the importance of testing, and complexities in integrating new technologies into existing healthcare systems.
Major market players included in this report are:
Abbott Laboratories
F. Hoffmann-La Roche Ltd
Sysmex Corporation
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
ARKRAY USA, Inc.
ACON Laboratories, Inc.
URIT Medical Electronic Co., Ltd.
ARKRAY Factory, Inc.
Carolina Liquid Chemistries Corp.
The detailed segments and sub-segments of the market are explained below:
By Product
Instruments
Consumables
By Application
Disease screening
Pregnancy and fertility
By End User
Hospitals and clinics
Diagnostic laboratories
Home care
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
The US Urinalysis Test Market is being driven by the increasing prevalence of chronic diseases, such as diabetes and kidney disorders, which necessitate regular urinalysis testing for early detection and management. This trend is particularly important as early intervention significantly improves patient outcomes and reduces healthcare costs. Additionally, the market is benefiting from the growing adoption of Point-Of-Care Testing (POCT), which offers rapid and convenient diagnostics, especially in remote or resource-limited settings However, there are also restraints impacting the market such as high costs of advanced equipment, economic disparities that restrict investment in new technologies, stringent regulatory requirements causing delays in product introduction, disparities in healthcare access impacting testing availability, limited awareness about the importance of testing, and complexities in integrating new technologies into existing healthcare systems.
Major market players included in this report are:
Abbott Laboratories
F. Hoffmann-La Roche Ltd
Sysmex Corporation
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
ARKRAY USA, Inc.
ACON Laboratories, Inc.
URIT Medical Electronic Co., Ltd.
ARKRAY Factory, Inc.
Carolina Liquid Chemistries Corp.
The detailed segments and sub-segments of the market are explained below:
By Product
Instruments
Consumables
By Application
Disease screening
Pregnancy and fertility
By End User
Hospitals and clinics
Diagnostic laboratories
Home care
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
CHAPTER 1. US URINALYSIS TEST MARKET DEFINITION AND RESEARCH ASSUMPTIONS
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US Urinalysis Test Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Product
2.2.2. By Application
2.2.3. By End User
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US URINALYSIS TEST MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US URINALYSIS TEST MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US URINALYSIS TEST MARKET SIZE & FORECASTS BY PRODUCT 2022-2032
5.1. Instruments
5.2. Consumables
CHAPTER 6. US URINALYSIS TEST MARKET SIZE & FORECASTS BY APPLICATION 2022-2032
6.1. Disease screening
6.2. Pregnancy and fertility
CHAPTER 7. US URINALYSIS TEST MARKET SIZE & FORECASTS BY END USER 2022-2032
7.1. Hospitals and clinics
7.2. Diagnostic laboratories
7.3. Home care
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. F. Hoffmann-La Roche Ltd
8.3.3. Sysmex Corporation
8.3.4. Beckman Coulter, Inc.
8.3.5. Bio-Rad Laboratories, Inc.
8.3.6. ARKRAY USA, Inc.
8.3.7. ACON Laboratories, Inc.
8.3.8. URIT Medical Electronic Co., Ltd.
8.3.9. ARKRAY Factory, Inc.
8.3.10. Carolina Liquid Chemistries Corp.
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US Urinalysis Test Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Product
2.2.2. By Application
2.2.3. By End User
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US URINALYSIS TEST MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US URINALYSIS TEST MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US URINALYSIS TEST MARKET SIZE & FORECASTS BY PRODUCT 2022-2032
5.1. Instruments
5.2. Consumables
CHAPTER 6. US URINALYSIS TEST MARKET SIZE & FORECASTS BY APPLICATION 2022-2032
6.1. Disease screening
6.2. Pregnancy and fertility
CHAPTER 7. US URINALYSIS TEST MARKET SIZE & FORECASTS BY END USER 2022-2032
7.1. Hospitals and clinics
7.2. Diagnostic laboratories
7.3. Home care
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. F. Hoffmann-La Roche Ltd
8.3.3. Sysmex Corporation
8.3.4. Beckman Coulter, Inc.
8.3.5. Bio-Rad Laboratories, Inc.
8.3.6. ARKRAY USA, Inc.
8.3.7. ACON Laboratories, Inc.
8.3.8. URIT Medical Electronic Co., Ltd.
8.3.9. ARKRAY Factory, Inc.
8.3.10. Carolina Liquid Chemistries Corp.
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
LIST OF TABLES
TABLE 1. US Urinalysis Test market, report scope
TABLE 2. US Urinalysis Test market estimates & forecasts by Product 2022-2032 (USD Million)
TABLE 3. US Urinalysis Test market estimates & forecasts by Application 2022-2032 (USD Million)
TABLE 4. US Urinalysis Test market estimates & forecasts by End User 2022-2032 (USD Million)
TABLE 5. US Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. US Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. US Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. US Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. US Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. U.S. Urinalysis Test market estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. U.S. Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 12. U.S. Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 13. List of secondary sources, used in the study of US Urinalysis Test Market.
TABLE 14. List of primary sources, used in the study of US Urinalysis Test Market.
TABLE 15. Years considered for the study.
TABLE 16. Exchange rates considered.
TABLE 1. US Urinalysis Test market, report scope
TABLE 2. US Urinalysis Test market estimates & forecasts by Product 2022-2032 (USD Million)
TABLE 3. US Urinalysis Test market estimates & forecasts by Application 2022-2032 (USD Million)
TABLE 4. US Urinalysis Test market estimates & forecasts by End User 2022-2032 (USD Million)
TABLE 5. US Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. US Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. US Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. US Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. US Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. U.S. Urinalysis Test market estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. U.S. Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 12. U.S. Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 13. List of secondary sources, used in the study of US Urinalysis Test Market.
TABLE 14. List of primary sources, used in the study of US Urinalysis Test Market.
TABLE 15. Years considered for the study.
TABLE 16. Exchange rates considered.
LIST OF FIGURES
FIG 1. US Urinalysis Test market, research methodology
FIG 2. US Urinalysis Test market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US Urinalysis Test market, key trends 2023
FIG 5. US Urinalysis Test market, growth prospects 2022-2032
FIG 6. US Urinalysis Test market, porters 5 force model
FIG 7. US Urinalysis Test market, pestel analysis
FIG 8. US Urinalysis Test market, value chain analysis
FIG 9. US Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 10. US Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 11. US Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 12. US Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 13. US Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 14. US Urinalysis Test market, company market share analysis (2023)
FIG 1. US Urinalysis Test market, research methodology
FIG 2. US Urinalysis Test market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US Urinalysis Test market, key trends 2023
FIG 5. US Urinalysis Test market, growth prospects 2022-2032
FIG 6. US Urinalysis Test market, porters 5 force model
FIG 7. US Urinalysis Test market, pestel analysis
FIG 8. US Urinalysis Test market, value chain analysis
FIG 9. US Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 10. US Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 11. US Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 12. US Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 13. US Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 14. US Urinalysis Test market, company market share analysis (2023)
